Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financi...(e herein speak only as of the date of th...),Health

    For more information, please contact:

    Shengtai Pharmaceutical, Inc.
     Ms. Yiru Melody Shi
     Chief Financial Officer
     Email: shengtaicfo@hotmail.com

    Grayling
     Eddie Cheung
     Investor Relations
     Tel:   +1-646-284-9414
     Email: eddie.cheung@us.grayling.com


                                Tables Follow


                        Shengtai Pharmaceutical, Inc.
                         Consolidated Balance Sheets
                    As of March 31, 2009 and June 30, 2008

                                      ASSETS
                                                March 31,          June 30,
                                                  2009               2008
                                               (Unaudited)
    CURRENT ASSETS:
      Cash                                $      2,249,064 $       3,405,606
      Restricted cash                            8,992,823         6,763,500
      Notes receivable                             149,447           458,630
      Accounts receivable, net of
       allowance for doubtful accounts
       of $492,918 and $440,701 as of
       March 31, 2009 and June 30,
       2008, respectively                        6,518,464         7,614,236
      Other receivables                            249,284           691,215
      Inventories                                6,929,686         5,039,278
      Prepayments                                  371,267           310,381
      Loan to related party                        439,500                --
        Total current assets                    25,899,535        24,282,846

    PLANT AND
'/>"/>
SOURCE  Shengtai Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 
Related medicine news :

1. Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call
2. Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for Facility Tour and Technology Exchange Conference
3. Shengtai Pharmaceutical, Inc. Comments On Its Operations
4. Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call
5. Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan
6. Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference
7. Shengtai Pharmaceutical Expands International Sales Program
8. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
9. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
10. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
11. Shengtai Pharmaceutical, Inc. to Present at Roth Conference